COVID-19 is an emerging, rapidly evolving situation.
NIH joins global effort to fund diabetes research
January / February 2014 | Volume 13, Issue 1
Updated August 24, 2015
NIH and other members of the Global Alliance for Chronic Diseases (GACD) have jointly announced a new series of research opportunities to tackle the global health burden of Type 2 diabetes, which is growing - especially in low-resource countries where 80 percent of people with the disease reside. This is the second GACD project, following the 2011 launch of grants targeting hypertension.
GACD said research proposals should aim to reduce health inequities in diabetes prevention and treatment, enhance knowledge that can be used for public benefit and produce scientific data to inform local and national health service providers and policymakers.
NIH is offering three options: Exploratory/developmental research grants may be funded for up to $275,000 over two years, small grant programs for up to $100,000 over two years and research project grants, lasting no longer than five years, with an unspecified funding level. The application deadlines are in February 2014.
NIH participants include Fogarty, the Office of Behavioral and Social Sciences Research (OBSSR), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), and National Heart, Lung and Blood Institute (NHLBI).
GACD is a collection of the world's biggest publicly-funded research agencies, including NIH, that represent more than three-quarters of public health research funding worldwide. The alliance coordinates and supports multi-country, multidisciplinary research covering life-style-related or chronic diseases, such as cardiovascular diseases, diabetes, certain cancers, lung disease and mental health. Projects focus on the particular needs of low- and middle-income country (LMIC) populations and also on vulnerable populations of more developed countries.
Awards for GACD / NIH Dissemination and Implementation Research in Health
To view Adobe PDF files,
download current, free accessible plug-ins from Adobe's website.